切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2018, Vol. 15 ›› Issue (04) : 294 -297. doi: 10.3877/cma.j.issn.1672-6448.2018.04.011

所属专题: 文献

生殖泌尿系统超声影像学

前列腺被膜支动脉阻力指数在前列腺癌预测或筛查中的临床价值
叶萍1, 钱孝纲1,(), 刘珣琪1, 吉紫佳1, 周鸿鸣1   
  1. 1. 江苏省常熟市第二人民医院超声科
  • 收稿日期:2017-08-24 出版日期:2018-04-01
  • 通信作者: 钱孝纲

Value of the resistance index of prostatic capsular artery in screening prostate cancer

Ping Ye1, Xiaogang Qian1,(), Xunqi Liu1, Zijia Ji1, Hongming Zhou1   

  1. 1. Department of Ultrasound, Changshu Hospital, Medical College of Yangzhou University, Changshu 215500, China
  • Received:2017-08-24 Published:2018-04-01
  • Corresponding author: Xiaogang Qian
  • About author:
    Corresponding author: Qian Xiaogang, Email:
引用本文:

叶萍, 钱孝纲, 刘珣琪, 吉紫佳, 周鸿鸣. 前列腺被膜支动脉阻力指数在前列腺癌预测或筛查中的临床价值[J]. 中华医学超声杂志(电子版), 2018, 15(04): 294-297.

Ping Ye, Xiaogang Qian, Xunqi Liu, Zijia Ji, Hongming Zhou. Value of the resistance index of prostatic capsular artery in screening prostate cancer[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2018, 15(04): 294-297.

目的

通过对前列腺被膜支动脉阻力指数(RI)与血清总前列腺特异性抗原(TPSA)浓度、fPSA/tPSA比值及前列腺特异性抗原密度(PSAD)的比较研究,以探讨前列腺被膜支动脉RI在前列腺癌预测或筛查中的临床价值。

方法

选取2012年1月至2016年10月在江苏省常熟市第二人民医院就诊的前列腺病患者203例。应用彩色多普勒超声分别行被膜支动脉RI、血清TPSA浓度、fPSA/tPSA比值及PSAD检测,并将患者分为前列腺癌组(118例)与前列腺增生组(85例),建立ROC曲线,计算曲线下面积。前列腺癌组与对照组RI、f/t、PSAD测值比较,采用t检验。

结果

血清TPSA浓度4~10 ng/ml(灰区)患者共34例,占总数的16.75%,其余患者均在灰区之外。ROC曲线分析显示:前列腺被膜支动脉RI曲线下面积为0.77与TPSA、PSAD的0.84、0.86相接近,三者对前列腺癌的预测或筛查价值相同,而fPSA/tPSA比值AUC仅0.49。灰区内fPSA/tPSA比值、PSAD的平均值在2组间比较,差异均有统计学意义(t=2.78、3.94,P均<0.01),但在灰区外高值区fPSA/tPSA比值,差异无统计学意义(P>0.05);而前列腺被膜支动脉RI的平均值无论是在灰区还是在灰区外高值区2组间比较,差异均有统计学意义(t=4.56、5.10,P均<0.001)。

结论

单项前列腺被膜支动脉RI因数据恒定能准确地用于前列腺癌预测或筛查,其不受灰区内外的影响,在临床上有较高的应用价值。

Objective

To explore the clinical value of resistance index (RI) of prostatic capsular artery in predicting or screening of prostate cancer (PCa) by comparing prostatic capsular artery RI with the serum total prostatic specific antigen (TPSA), fPSA/tPSA ratio and prostatic specific antigen dernsity (PSAD).

Methods

RI of prostate capsular artery, serum TPSA, of fPSA/tPSA ratio and PSAD were measured with colour Doppler ultrasonography in this subset of 203 patients who had undergone transrectal ultrasound guided prostate puncture biopsy. The patients were divided into two groups [PCa and benign prostatic hyperplasia (BPH) group] for comparative study.

Results

Of them, the level of TPSA were between 4 and 10 ng/ml (grey area) in 34 cases, accounts for 16.75% of the total subjects. All the others were outside the grey area. ROC curve analysis showed that the area under the curve (AUC) of RI of the capsular artery was 0.77, which was close to 0.84 and 0.86 of TPSA and PSAD. It indicated a similar value in predicting or screening PCa; while the AUC of fPSA/tPSA ratio was only 0.49, which had little clinical value. The fPSA/tPSA ratio and the mean value of PSAD in the grey area had significant differences (t=2.78, 3.94, P<0.02) between the two groups. However, the fPSA/tPSA ratio had no statistical significance in the high value area outside the grey area (t=0.873, P>0.05). And the mean value of RI of prostatic capsular artery had significant differences between the two groups both in the grey area and in the high value area outside the grey area (t=4.56, 5.10, P<0.001).

Conclusions

RI of prostatic capsular artery can be steadily used to predict or screen PCa. It is not affected by the gray area of TPSA and is of great value in clinical practice.

图1 前列腺供血动脉声像图
图2 RI、TPSA、f/t和PSAD的ROC曲线图
表1 RI与血清TPSA浓度、f/t比值及PSAD的曲线下面积比较
表2 前列腺癌组与对照组患者被膜支动脉RI、f/t比值、PSAD比较(±s
[1]
冯陶, 黄有媛, 窦长琪, 等. 血清游离和总前列腺特异抗原测定在前列腺良恶性病变中的价值[J]. 中华泌尿外科杂志, 2002, 23(1): 26-28.
[2]
张海洋, 王慕文, 赵勇, 等. 前列腺癌的诊断和治疗现状的探讨[J/CD]. 泌尿外科杂志(电子版), 2013, 5(2): 8-14.
[3]
吴杰, 赵睿哲, 黄源, 等. PSA"灰区"前列腺癌预测模型及随访系统的建立[J]. 中华泌尿外科杂志, 2016, 37(4): 280-283.
[4]
韩刚, 高江平, 陈宇东, 等. 综合评价新参数(F/T) /PSAD对PSA灰区前列腺癌的诊断价值[J]. 中华泌尿外科杂志, 2013, 31(7): 514-517.
[5]
许清江, 许恩赐, 李梦强. 前列腺特异性抗原密度对临床局限性前列腺癌术后病理包膜外侵犯的预测价值[J]. 中华泌尿外科杂志, 2015, 36(12): 910-913.
[6]
钱孝纲. 前列腺癌与前列腺被膜支动脉阻力指数的相关性分析[J]. 中国超声医学杂志, 2010, 26(9): 822-825.
[7]
Zhang X,Li G,Hu L, et al. Resistive index of prostatic capsular arteries as a prediclor of prostate cancer in patiens undergoing initial prostate biopsy[J]. Med Oncol, 2014, 31(12): 297.
[8]
Neumaier CE,Martinoli C,Derchi LE, et al. Normal prostate gland: examination with color Doppler US[J]. Radiology, 1995, 196(2): 453-457.
[9]
陈建森, 李鸣. PSA灰区前列腺癌诊断进展[J]. 国际泌尿系统杂志, 2016, 36(6): 923-925.
[10]
王莉, 赵娅南, 李志燕. TPSAˎ FPSAˎ FPSA/TPSA和Ferr检测对前列腺癌的诊断价值[J].标记免疫分析与临床, 2014, 21(2): 160-162.
[11]
Lacher DA,Hughes JP. Total, free, and complexed prostate-specific antigen levels among US men 2007-2010[J]. Clin Chim Acta, 2015, 448: 220-227.
[12]
Chang CC,Lee YC,Tsai HW, et al. Diagnostic role of serum Free-to-Total prostate specific antigen(PSA) ratio in prostate cancer with serum total concentration of PSA below 4ng/ml[J]. Asian Pac J Cancer Prev, 2015, 16(13): 5261-5264.
[13]
钱孝纲, 殷理, 顾佳, 等. 前列腺被膜支动脉血流动力学相关参数在前列腺癌筛查中的临床意义[J]. 中华超声影像学杂志, 2013, 22(3): 270-271.
[14]
Allepuz Losa CA,Gil Sanz MJ,Gonzalvo Ibarra A, et al. The early diagnosis of prostate cancer in a selected population. The usefulness of PSAD, PSAD ad. and age-adjusted PSA in patients with a PSA between 4-10 ng/ml[J]. Actas Urol Esp, 1997, 21(4): 344-353.
[15]
Rahardio D,Kamil ST,Pakasi LS. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence[J]. Gan To Kagakn Ryoho, 2000, 27 suppl 2: 563-570.
[1] 孔凡雷, 方建华, 徐陈柯, 张丽青, 包凌云, 雷志锴. 超声与MRI融合导航穿刺在前列腺癌Gleason分级中的应用研究[J]. 中华医学超声杂志(电子版), 2019, 16(11): 860-864.
[2] 王琦, 蔡杰, 欧彤文, 崔昕, 吴江涛, 陈晓松. MRI-TRUS融合引导经会阴前列腺靶向结合饱和穿刺活检的临床应用[J]. 中华医学超声杂志(电子版), 2019, 16(06): 458-464.
[3] 梁健, 何京伟, 关文峰, 梁其炎, 冯能卓, 黄亦欣, 覃文超. 多参数MRI与超声认知融合引导下前列腺靶向穿刺的前瞻性研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 558-562.
[4] 李腾成, 谭益元, 黄群雄, 吴杰英, 肖恒军, 胡成, 李茂胤, 高新, 狄金明. 机器人腹腔镜后入路完全筋膜内根治性前列腺切除术治疗早期前列腺癌[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 452-456.
[5] 梅津熠, 王燕, 瞿旻, 董振阳, 周增辉, 沈显琦, 李嘉伦, 高旭. 机器人前列腺癌根治术中"膀胱外中叶"的处理[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 429-433.
[6] 蔡蓝蝶, 何君伟, 胡萍, 潘俊, 汤桂兴, 白遵光. 前列腺小细胞癌三例诊疗分析并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 397-402.
[7] 李腾成, 狄金明. 2023 V1版前列腺癌NCCN指南更新要点解读[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 313-318.
[8] 单兴利, 王栋, 邢念增, 肖泽均, 李亚健. 68Ga-PSMA-PET/CT对前列腺癌盆腔淋巴结转移诊断价值的研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 214-218.
[9] 谢秋波, 周宇, 宋健, 涂忠, 李想, 汪仁昊, 伍依依, 潘铁军. 全息影像在机器人辅助前列腺癌根治术中保留膀胱颈的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 209-213.
[10] 邵浩仁, 郭佳. 铁死亡的分子机制及其在前列腺癌治疗中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 294-298.
[11] 郑嘉裕, 吴建杰, 李小娟, 曾恒达, 李国邦, 黄炯煅, 温星桥. hsa_circ_0090923在前列腺癌中的表达及其对前列腺癌细胞增殖和迁移的调控[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 276-283.
[12] 秦露平, 吕杰, 李名钊, 李建芳, 谢良骏, 李锦萍, 程木华. 68Ga-PSMA-11 PET/CT延迟显像探测前列腺癌根治术后盆腔复发的价值[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(05): 378-382.
[13] 朱惠, 陶吴东, 黄彬, 阳东荣, 张娟. 血浆纤维蛋白原与前列腺癌骨转移的相关性及诊断价值研究[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 135-138.
[14] 陈化磊, 卓小岸, 卓小丽, 车宪平, 胡鑫明. 3D与2D腹腔镜前列腺癌根治术治疗前列腺癌的临床疗效比较[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 130-134.
[15] 李腾成, 蔡有弟, 王喻, 肖楚天, 孙卓伦, 高新, 温星桥. 新型冠状病毒肺炎疫情下临床治疗前列腺疾病的策略与建议[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(02): 88-90.
阅读次数
全文


摘要